Table 3.
Number of eligible patients | QALY and impact | ||||||
---|---|---|---|---|---|---|---|
High | Low | ||||||
QALY | Impact | QALY | Impact | ||||
Euflexxa | Current use | High | 331,401 | 0.1596 | 52,891 | 0.1064 | 35,261 |
Low | 220,934 | 35,261 | 23,507 | ||||
Additional | High | 3,330,960 | 531,621 | 354,414 | |||
Low | 2,220,640 | 354,414 | 236,276 | ||||
Maximum | High | 3,662,362 | 584,512 | 389,675 | |||
Low | 2,441,574 | 389,675 | 259,783 | ||||
Appropriate care | Maximum | High | 7,402,964 | 0.036 | 266,506 | 0.024 | 177,671 |
Low | 4,935,309 | 177,671 | 118,447 |